Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mariona Calvo
Institutions:
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia
Observed institutions:
Bellvitge University Hospital,
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Hopital Universitaire Hedi Chaker,
Duran i Reynals Hospital,
Universitat de Barcelona
show all 6
ORCID:
0000-0001-6242-0500
Observed ORCID:
0000-0001-6242-0500
OpenAlex ID:
A5108852002
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
2023
·
Shubham Pant
, Martin Schuler
, et al.
·
The Lancet Oncology
·
239
PDF
Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours
2014
·
Mar Marin
, Carlota Gudiol
, et al.
·
Journal of Infection
·
131
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
2021
·
Ester Gonzalez-Sanchez
, Javier Vaquero
, et al.
·
Cancers
·
109
PDF
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients
2013
·
Marta Bodro
, Carlota Gudiol
, et al.
·
Supportive Care in Cancer
·
98
A fresh look at polymicrobial bloodstream infection in cancer patients
2017
·
Cristina Royo-Cebrecos
, Carlota Gudiol
, et al.
·
PLoS ONE
·
69
PDF
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
2021
·
Sergio Muñoz-Martínez
, Victor Sapena
, et al.
·
JHEP Reports
·
66
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series
2022
·
Carla Marco
, Marta Simó
, et al.
·
Journal of Clinical Medicine
·
40
PDF
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience
2020
·
Roser Velasco
, Sarah Besora
, et al.
·
Anti-Cancer Drugs
·
28
Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma
2023
·
Rut Espinosa-Sotelo
, Noel P. Fusté
, et al.
·
Redox Biology
·
19
Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results
2023
·
Fortunato Ciardiello
, Yung‐Jue Bang
, et al.
·
Cancer Medicine
·
18
PDF
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
2025
·
Josep Amengual
, Ester Gonzalez-Sanchez
, et al.
·
Signal Transduction and Targeted Therapy
·
16
Mevrometostat (PF-06821497), an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study.
2025
·
Michael Thomas Schweizer
, Mariona Calvo
, et al.
·
Journal of Clinical Oncology
·
15
PDF
Treatment of complete esophageal stenosis using endoscopic ultrasound-guided puncture: a novel technique for access to the distal lumen
2014
·
Joan Gornals
, Claudia Consiglieri
, et al.
·
Endoscopy
·
12
PDF
Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study
2019
·
Manuel Puga
, Nat�lia Pallar�s
, et al.
·
Revista Española de Enfermedades Digestivas
·
11
SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)
2024
·
Carlos López López
, Mariona Calvo
, et al.
·
Clinical & Translational Oncology
·
10
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy
2025
·
Marta Fortuny
, Leonardo G. da Fonseca
, et al.
·
Liver International
·
8
PDF
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study
2025
·
Maria Alsina
, Guillermo Villacampa
, et al.
·
Clinical Cancer Research
·
8
PDF
Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre
2017
·
Maria Saigí
, Marc Oliva
, et al.
·
PLoS ONE
·
8
PDF
A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant prostate cancer (mCRPC).
2023
·
Mariona Calvo
, Konstantin Penkov
, et al.
·
Journal of Clinical Oncology
·
7
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
2020
·
Paula Jimenez-Fonseca
, Alberto Carmona-Bayonas
, et al.
·
Gastric Cancer
·
7
PDF
MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC).
2021
·
MARIA ALSINA
, Mariano Ponz-Sarvise
, et al.
·
Journal of Clinical Oncology
·
3
Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT
2026
·
Mario Balsa
, Sergio Alonso
, et al.
·
Cancer Treatment Reviews
·
2
Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives
2026
·
Mar Teixidó Mulet
, Joel Veas Rodriguez
, et al.
·
Cancer Treatment Reviews
·
2
PDF
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry
2025
·
Carlos López-López
, Eva Martínez de Castro
, et al.
·
Clinical & Translational Oncology
·
2
PDF
New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor‐Beta in Liver Tumorigenesis
2025
·
Ana Cantos‐Cortes
, Josep Amengual
, et al.
·
Liver International
·
1
Show more works
View as search
Works count:
62
Citation count:
937
H-index:
12
I10-index:
15
Year
Topic
Type